Publications by authors named "Anna Lomax"

Claim this Profile
P
PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
Tahlia Scheinberg, Anna Lomax, Martin Tattersall, David Thomas, Geoff McCowage

Cancer Rep (Hoboken)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti-PD-1 therapy.
Anna J Lomax, Peter I A McQuillan, Anthony Hall, Grant A McArthur

Intern Med J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy.
David Levy, Haryana M Dhillon, Anna Lomax, Michael Marthick, Catriona McNeil

Support Care Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability.
Judith Lacey, Anna J Lomax, Catriona McNeil, Michael Marthick, David Levy

Support Care Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.
Aflah Roohullah, Adam Cooper, Anna J Lomax, Jennifer Aung, Alan Barge

Invest New Drugs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Jennifer Lim, Anna J Lomax, Catriona McNeil, Brian Harrisberg

Ocul Immunol Inflamm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management.
Anna J Lomax, Jennifer Lim, Robert Cheng, Arianne Sweeting, Patricia Lowe

J Skin Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.
Anna J Lomax, Helen M McGuire, Catriona McNeil, Clara J Choi, Peter Hersey

Int J Rheum Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Georgina V Long, Victoria Atkinson, Jonathan S Cebon, Michael B Jameson, Bernie M Fitzharris, Anna J Lomax

Lancet Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Nurse Consultant Support: Management of Patients With Melanoma Receiving Immunotherapy 
and Targeted Therapy
.
Anna J Lomax, Theresa Nielsen, Lydia Visintin, Brent O'Carrigan, Florian Honeyball

Clin J Oncol Nurs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute management of autoimmune toxicity in cancer patients on immunotherapy: Common toxicities and the approach for the emergency physician.
Anna J Lomax, Catriona McNeil

Emerg Med Australas· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous pemphigoid-like reaction in a patient with metastatic melanoma receiving pembrolizumab and previously treated with ipilimumab.
Anna J Lomax, Ludi Ge, Sunaina Anand, Catriona McNeil, Patricia Lowe

Australas J Dermatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
Hui-Li Wong, Belinda Lee, Kathryn Field, Anna Lomax, Mark Tacey

Clin Colorectal Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme.
Anna J Lomax, Prue A Hill, David M Ashley

J Oncol Pharm Pract· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial.
Anna J Lomax, Saw Yee Yap, Karen White, Jane Beith, Ehtesham Abdi

J Bone Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma.
Anna J Lomax, Costas K Yannakou, Mark A Rosenthal

Target Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis